Related Experiment Video
Updated: Feb 15, 2026
Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
[Treatment of speech disorders in preschool children]
V F Shalimov1, N Yu Suvorinova2, Yu E Nesterovsky2
1Serbsky Federal Medical Research Center of Psychiatry and Addiction, Moscow, Russia.
Insights
Neyroferon shows promise in improving speech and reducing behavioral issues in children with developmental speech disorders (SDD). This preliminary study indicates a therapeutic effect and confirmed drug safety.
Area of Science:
- Pediatric Neurology
- Speech-Language Pathology
Background:
- Developmental Speech Disorders (SDD) affect numerous preschool children, impacting communication and behavior.
- Early intervention is crucial for managing SDD and improving long-term outcomes.
Purpose of the Study:
- To evaluate the efficacy of Neyroferon in treating developmental speech disorders (SDD) in preschool children.
- To assess the impact of Neyroferon on speech parameters and behavioral characteristics.
Main Methods:
- A study involving 30 preschool children diagnosed with SDD, stratified by age groups (4-5, 5-6, 6-7 years).
- Participants received Neyroferon (1 tablet, 3 times daily for 2 months).
- Comprehensive speech disorder assessment, alongside evaluation of mental state, emotional, and behavioral traits.
Main Results:
- Neyroferon demonstrated a therapeutic effect, enhancing auditory-speech memory, expressive speech, phonemic perception, and vocabulary.
- Improvements were observed in articulatory movements, connected speech, and a reduction in anxiety, hyperactivity, and attention deficits.
- The safety profile of Neyroferon was confirmed during the study period.
Conclusions:
- Neyroferon shows potential as a treatment for developmental speech disorders, positively influencing speech functions and behavior.
- The drug was found to be safe for use in the studied pediatric population.
- These findings are preliminary and warrant further investigation to confirm efficacy and long-term benefits.
Aim:
To study the efficacy of neyroferon in developmental speech disorders (SDD).
Material And Methods:
Thirty preschool children were stratified into 3 groups: 4-5 years (n=8), 5-6 years (n=10) and 6-7 years (n=12). The children were treated with neyroferon in dose 1 tablet three times a day during 2 month. A multifaceted study of speech disorders using several methods was conducted. General mental state, emotional and behavioral characteristics of the children were assessed as well.
Results And Conclusion:
A therapeutic effect of neyroferon (the improvement of auditory-speech memory, expressive speech, phonemic perception, articulatory movements, vocabulary activity, connected speech etc) as well as the decrease in anxiety, hyperactivity and attention deficit was found in children with SDD. The safety of the drug was confirmed. The results should be treated as preliminary ones.
More Related Videos
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
02:18Intrinsically Disordered Proteins
01:29Drug Dosing: Infants and Children
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...